Due to the wide expression of PRLR in almost all types of breast cancers, fusion protein MICA-G129R can be used for many types of breast cancers regardless the common classification with ER, PR, HER2 or triple negative breast cancers. Here, MICA is linked to triple-negative breast carcinoma.